CEO of Alnylam Pharmaceuticals Inc (30-Year Financial, Insider Trades) John Maraganore (insider trades) sold 34,765 shares of ALNY on 05/20/2020 at an average price of $143.22 a share. The total sale was $5 million.
Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes. Alnylam Pharmaceuticals Inc has a market cap of $16.13 billion; its shares were traded at around $140.52 with and P/S ratio of 54.46. GuruFocus has detected 2 severe warning signs with Alnylam Pharmaceuticals Inc. .
CEO Recent Trades:
- CEO John Maraganore sold 34,765 shares of ALNY stock on 05/20/2020 at the average price of $143.22. The price of the stock has decreased by 1.89% since.
Directors and Officers Recent Trades:
- President Barry E Greene sold 22,265 shares of ALNY stock on 05/06/2020 at the average price of $149.99. The price of the stock has decreased by 6.31% since.
- COO Yvonne Greenstreet sold 57,811 shares of ALNY stock on 05/06/2020 at the average price of $148.65. The price of the stock has decreased by 5.47% since.
For the complete insider trading history of ALNY, click here
.
